We are live on ! Find out more
ENTX icon

Entera Bio
ENTX

15 hedge funds and large institutions have $7.11M invested in Entera Bio in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

192% more capital invested

Capital invested by funds: $2.44M → $7.11M (+$4.68M)

50% more funds holding

Funds holding: 10 → 15 (+5)

2.1% less ownership

Funds ownership: 14.11% → 12.01% (-2.1%)

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
7
Increased
3
Reduced
1
Closed
2
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
-$18K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$165K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$57K
3
VF
Virtu Financial
New York
+$24.3K
4
Renaissance Technologies
Renaissance Technologies
New York
+$19.3K
5
Citadel Advisors
Citadel Advisors
Florida
+$13.8K

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$41.7K
2
Morgan Stanley
Morgan Stanley
New York
-$1.2K
3
Group One Trading
Group One Trading
Illinois
-$324
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$6.48M – – –
UBS Group
2
UBS Group
Switzerland
$250K +$165K +149,869 New
Renaissance Technologies
3
Renaissance Technologies
New York
$125K +$19.3K +17,500 +30%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$86.2K +$57K +51,628 New
VF
5
Virtu Financial
New York
$37K +$24.3K +22,040 New
Millennium Management
6
Millennium Management
New York
$32.6K +$10.4K +9,413 +93%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$29.4K – – –
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
$21.7K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$20.9K +$13.8K +12,502 New
HighTower Advisors
10
HighTower Advisors
Illinois
$20K – – –
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$5K +$3.09K +2,800 +1,400%
Osaic Holdings
12
Osaic Holdings
Arizona
$2.5K +$1.66K +1,500 New
Group One Trading
13
Group One Trading
Illinois
$85 -$324 -294 -85%
JP Morgan Chase
14
JP Morgan Chase
New York
$3 +$2 +2 New
TSS
15
Two Sigma Securities
New York
– -$41.7K -69,441 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$1.2K -2,000 Closed
Simplex Trading
17
Simplex Trading
Illinois
– +$326 +295 New

ENTX Hedge Fund Activity: Q1 2024 in Review

15 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2024, worth a combined $7.11M — up 192% from $2.44M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ENTX positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $165K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $41.7K sold.

  • 15 institutional investors held Entera Bio (ENTX) as of Q1 2024, up from 10 in Q4 2023.
  • Funds reported $7.11M of Entera Bio stock for Q1 2024, up 192% quarter-over-quarter.
  • 7 funds opened new Entera Bio positions in Q1 2024 and 2 closed out, a net change of +5 holders.
  • The largest Entera Bio buyer in Q1 2024 was UBS Group, an estimated $165K added.
  • The largest Entera Bio seller in Q1 2024 was Two Sigma Securities, an estimated $41.7K sold.

Based on aggregated 13F filings for Q1 2024.